TY - JOUR
T1 - Level and trend of total plasma cholesterol in national and subnational of Iran
T2 - a systematic review and age-spatio-temporal analysis from 1990 to 2016
AU - Mehdipour, Parinaz
AU - Mohammadi, Esmaeil
AU - Sepanlou, Sadaf G.
AU - Ahmadvand, Alireza
AU - Peykari, Niloofar
AU - Djalalinia, Shirin
AU - Rezaei-Darzi, Ehsan
AU - Mohebi, Farnam
AU - Moradi, Yousef
AU - Samaei, Mehrnoosh
AU - Khosravi, Ardeshir
AU - Jamshidi, Hamidreza
AU - Farzadfar, Farshad
AU - Azizi, Fereydoun
AU - Khalili, Davood
AU - Khoshnia, Masoud
AU - Kouhpayehzadeh, Jalil
AU - Malekzadeh, Reza
AU - Merat, Shahin
AU - Mirzazadeh, Ali
AU - Mohammad, Kazem
AU - Mohammadifard, Noushin
AU - Nabipour, Iraj
AU - Parsaeian, Mahboubeh
AU - Pourshams, Akram
AU - Poustchi, Hossein
AU - Sarrafzadegan, Nizal
AU - NASBOD Risk Collaborating Group
N1 - Publisher Copyright:
© 2022, Springer Nature Switzerland AG.
PY - 2022/12
Y1 - 2022/12
N2 - Purpose: We aimed to estimate the level and trend of plasma cholesterol and raised total cholesterol (TC > 200 mg/dl) prevalence at national and subnational level of Iran. Methods: Nine national surveys and 27 studies, encompassing 3,505 unique points on over 500,000 adults, aged > 25 years with a report of laboratory measurement of TC were found. Age-spatio-temporal model and Gaussian Process Regression were used to estimate mean TC for each sex, 5-year age groups, and 31 provinces from 1990 to 2016. Results: At national level, age-standardized prevalence of TC > 200 mg/dL has decreased from 57·2%(53·3–61·1) to 22·4%(20·5–24·3) in women and 53·2%(49·1–57·3) to 18·0%(16·4–19·6) in men. TC distribution presented a condensation between 170-200 mg/dL. At subnational level, decreasing and converging patterns of raised TC prevalence were detected. Conclusion: The decrease in raised TC is likely the result of statin widespread use, food industry improvements, and the expanded primary health care.
AB - Purpose: We aimed to estimate the level and trend of plasma cholesterol and raised total cholesterol (TC > 200 mg/dl) prevalence at national and subnational level of Iran. Methods: Nine national surveys and 27 studies, encompassing 3,505 unique points on over 500,000 adults, aged > 25 years with a report of laboratory measurement of TC were found. Age-spatio-temporal model and Gaussian Process Regression were used to estimate mean TC for each sex, 5-year age groups, and 31 provinces from 1990 to 2016. Results: At national level, age-standardized prevalence of TC > 200 mg/dL has decreased from 57·2%(53·3–61·1) to 22·4%(20·5–24·3) in women and 53·2%(49·1–57·3) to 18·0%(16·4–19·6) in men. TC distribution presented a condensation between 170-200 mg/dL. At subnational level, decreasing and converging patterns of raised TC prevalence were detected. Conclusion: The decrease in raised TC is likely the result of statin widespread use, food industry improvements, and the expanded primary health care.
KW - Cholesterol
KW - Hypercholesterolemia
KW - Iran
KW - Longitudinal studies
KW - Prevalence
KW - Systematic review and meta-analysis
UR - https://www.scopus.com/pages/publications/85133879147
U2 - 10.1007/s40200-022-01052-w
DO - 10.1007/s40200-022-01052-w
M3 - Review Article
AN - SCOPUS:85133879147
SN - 2251-6581
VL - 21
SP - 1301
EP - 1315
JO - Journal of Diabetes and Metabolic Disorders
JF - Journal of Diabetes and Metabolic Disorders
IS - 2
ER -